Bengaluru, India

Reshmi Bhattacharjee

This inventor holds 1 USPTO granted patent. Top assignee: Koninklijke Philips Corporation N.v.. Active years: 2021.


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2021

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Reshmi Bhattacharjee: Innovating Proton Therapy in Bengaluru

Introduction

Reshmi Bhattacharjee is a notable inventor based in Bengaluru, India, renowned for her contributions to the field of proton therapy. With a focus on enhancing the precision of cancer treatments, her innovations aim to optimize patient outcomes and streamline therapeutic processes.

Latest Patents

Reshmi holds a patent for "Robust broad beam optimization for proton therapy." This invention introduces robustness optimization for a broad beam proton therapy plan, where a nominal dose distribution is computed to be delivered to a targeted volume. The patent outlines a method to adjust the parameters of the proton therapy plan in order to reduce the discrepancies between the nominal dose distribution and any perturbed dose distributions, which may result from various error scenarios. This adjustment process can be repeated serially to create a robust proton therapy plan capable of addressing multiple error scenarios effectively.

Career Highlights

Reshmi Bhattacharjee is currently associated with Koninklijke Philips Corporation N.V., where she leverages her expertise in health technology to advance medical treatments. Her work in this prestigious company underscores her dedication to improving healthcare through innovation.

Collaborations

Throughout her career, Reshmi has collaborated with esteemed colleagues, including Vaitheeswaran Ranganathan and Gipson Joe Anto. Their teamwork reflects a commitment to pushing the boundaries of technology in the medical field and enhancing therapeutic methodologies.

Conclusion

Reshmi Bhattacharjee exemplifies the spirit of innovation in the medical technology sector, particularly in her advancements in proton therapy. Her contributions not only reflect her technical acumen but also her dedication to improving patient care. As she continues her work at Koninklijke Philips Corporation N.V., the future looks promising for both her and the field she passionately serves.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…